Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Pharmacogenetics and Genomics|August 15, 2012
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's diseaseMonika Białecka, Mateusz Kurzawski, Anna Roszmann, et al.
Schizophrenia Research|July 5, 2017
Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophreniaMonika Mak, Błażej Misiak, Dorota Frydecka, et al.
BMC Psychiatry|June 27, 2024
Impulsivity and inhibitory control in deficit and non-deficit schizophreniaMaksymilian Bielecki, Ernest Tyburski, Piotr Plichta, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2022
Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controlsAnna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Journal of Psychiatric Research|May 10, 2024
Greater methylation of the IL-6 promoter region is associated with decreased integrity of the corpus callosum in schizophreniaAnna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Journal of Clinical Medicine|November 11, 2022
Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic PsychosisAnna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Journal of Clinical Medicine|June 2, 2021
White Matter Integrity of the Corpus Callosum and Psychopathological Dimensions in Deficit and Non-Deficit Schizophrenia PatientsPiotr Podwalski, Ernest Tyburski, Krzysztof Szczygieł, et al.
Pageof 6